These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31565597)

  • 1. Clinical Efficacy of Ketamine for Treatment-resistant Depression.
    Bratsos S; Saleh SN
    Cureus; 2019 Jul; 11(7):e5189. PubMed ID: 31565597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Ketamine in the Treatment of Psychiatric Disorders.
    Derakhshanian S; Zhou M; Rath A; Barlow R; Bertrand S; DeGraw C; Lee C; Hasoon J; Kaye AD
    Health Psychol Res; 2021; 9(1):25091. PubMed ID: 35106397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ketamine in treatment-resistant depression: a systematic review.
    Serafini G; Howland RH; Rovedi F; Girardi P; Amore M
    Curr Neuropharmacol; 2014 Sep; 12(5):444-61. PubMed ID: 25426012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The symptoms of major depression.
    Buchwald AM; Rudick-Davis D
    J Abnorm Psychol; 1993 May; 102(2):197-205. PubMed ID: 8315132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could ketamine be the answer to treating treatment-resistant major depressive disorder?
    Ramadan AM; Mansour IA
    Gen Psychiatr; 2020; 33(5):e100227. PubMed ID: 32875273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing the Range of Mood Disorders in Women.
    Downey JI
    Medscape Womens Health; 1996 Aug; 1(8):4. PubMed ID: 9746637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression.
    Kim YK; Na KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():117-26. PubMed ID: 27046518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study.
    McGirr A; Renaud J; Seguin M; Alda M; Benkelfat C; Lesage A; Turecki G
    J Affect Disord; 2007 Jan; 97(1-3):203-9. PubMed ID: 16854469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives.
    Shin C; Kim YK
    Psychiatry Investig; 2020 Mar; 17(3):181-192. PubMed ID: 32209965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine: Future Treatment For Unresponsive Depression?
    Frere M; Tepper J
    Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease.
    Mohammad Shehata I; Masood W; Nemr N; Anderson A; Bhusal K; Edinoff AN; Cornett EM; Kaye AM; Kaye AD
    Neurol Int; 2022 Mar; 14(2):310-321. PubMed ID: 35466206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.